jublipharma

Pharmaceutical maker Jubilant Pharmova, wholly owned subsidiary Jubilant Pharma Limited, through one of its wholly owned subsidiaries, Jubilant HollisterStier General Partnership, will invest $76.6 million to expand capacity at its Contract Manufacturing Organization (CMO) Montreal, Canada facility. Jubilant will receive a more than $19 million loan from the Government of Quebec through its agent Investissement Quebec, including a forgivable portion of nearly $5 million.

“Jubilant HollisterStier is chosen as a part of the eco-system being developed by Canada to make it self-dependent for its future needs of vaccines and treatments in case of a pandemic